Not currently recruiting at UC Irvine
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease
Summary
- Eligibility
- for people ages 18-65 (full criteria)
- Location
- at Orange, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- Janssen Research & Development, LLC
- ID
- NCT05242471
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- Expecting 715 study participants
- Last Updated